AGNISTABIO Trademark
Serial Number: 98525680
Trademark Classes
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Owner Contact Info
Legal Representation
Correspondence Address
Enshan Hong MagStone Law, LLP
293 Eisenhower Pkwy, Suite 135
Livingston, NJ 07039
United States
Trademark Details
Filing Date
April 29, 2024
Registration Date
Not Registered
Published for Opposition
December 17, 2024
Goods & Services
Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies; legal services
Providing medical information in the field of inflammatory disease, immune related diseases, disorders and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of cancer, tumor, malignancies, and related diseases, disorders, and conditions prevention, screening, diagnosis and treatment; providing medical information in the field of eye diseases, cardiovascular diseases, and brain disorder prevention, screening, diagnosis and treatment
Medical and scientific research in the field of inflammatory diseases, immune related diseases, disorders, and conditions treatment and diagnosis; medical and scientific research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions treatment and diagnosis; Medical and scientific research in the field of eye diseases, cardiovascular diseases and brain disorders treatment and diagnosis; Clinical research in the field of inflammatory diseases, immune related diseases, disorders, and conditions; Clinical research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of eye diseases, cardiovascular diseases and brain disorders, and conditions; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Scientific research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical and biopharmaceutical research services in the fields of inflammatory diseases, immune related diseases, disorders, and conditions, cancer, tumors, malignancies, and related diseases, disorders, conditions, eye diseases, cardiovascular diseases, and brain disorders; Pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; Pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; Software as a service services featuring artificial intelligence software for drug discovery and development; Scientific and technological services and research and design relating thereto in the nature of pharmaceutical research and development; Industrial analysis and research services in the nature of pharmaceutical research and development; Design and development of computer hardware and software
Pharmaceutical preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; biological preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; pharmaceutical preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; biological preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; pharmaceutical preparations for the treatment of eye diseases; biological preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; biological preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of brain disorders; biological preparations for the treatment of brain disorders